Valentina Prevolnik Rupel: No One Should Be Left Behind

Valentina Prevolnik Rupel

Why U.S. Mortality Rates Exceed Other Wealthy Nations

U.S.- OncoDaily

Thomas L. Harrison Joins the Board of Directors of P53 Inc.

Thomas L. Harrison

TRYBECA-1 Trial: Eryaspase Added to Second-Line Chemotherapy in Advanced PDAC

TRYBECA-1 Trial

Rossana Berardi: Honored to Have Been Elected President-Elect of AIOM

Rossana Berardi

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Collaborative Discussion on Europe’s Cancer Policy Future at ECHoS Town Hall Meeting

ECHoS

Armand Cognetta: General Proximity Will Collaborate with Daiichi Sankyo US

Armand Cognetta

OncoCalendar

« All Events

  • This event has passed.

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference

Nov 15, 2024 • 12:00 AM - Nov 17, 2024 • 12:00 AM
ESH-EBMT-EHA-IPIG 3rd Translational Research Conference

The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024.

It will offer valuable insights for both clinical and non-clinical scientists, including M.D.s and Ph.D.s of all levels, who are interested in the biology, pathophysiology, diagnosis, and treatment of bone marrow failure syndromes (BMFS) and predisposition syndromes. The conference will address both acquired and inherited BMFS in adults and children, with a particular focus on emerging principles and innovative treatment strategies.

As is customary for ESH, the event will prioritize accessible interactions between young researchers and established experts, as well as between clinicians and basic scientists. Workshops with experts and poster walks will emphasize key topics and provide opportunities for in-depth discussion. The distinguished faculty will ensure a high standard of clinical, translational, and basic research is maintained throughout the conference.

For Registration Visit Here

Details

Organizer

Venue